Scienture (SCNX) vs Silo Pharma (SILO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Scienture is the larger company by market cap ($4.1 million vs $3.7 million), about 1.1 times the size. Silo Pharma converts more of its revenue into profit, with a net margin of -5863.5% versus -9618.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SCNX | SILO |
|---|---|---|
| Share price | $2.28 | $1.71 |
| Market cap | $4.07M | $3.69M |
| 1-day change | -6.45% | -9.04% |
| EPS (TTM) | $-51.70 | $-2.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $431.61K | $72.10K |
| Revenue growth (YoY) | +215.87% | 0.00% |
| Net income (latest FY) | $-41.51M | $-4.23M |
| Gross margin | 76.80% | 38.57% |
| Operating margin | -9867.92% | -5936.95% |
| Net margin | -9618.03% | -5863.50% |
| 52-week high | $18.75 | $10.43 |
| 52-week low | $2.00 | $1.10 |
| Distance from 52-week high | -87.85% | -83.60% |
| Analyst consensus | buy | — |
| Avg. price target upside | +1546.25% | — |
| Average volume | 156.51K | 65.47K |
| Shares outstanding | 1.79M | 2.16M |
| Employees | 4 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Silo Pharma is more profitable, keeping -5863.5 cents of every revenue dollar as net income versus -9618.0 cents for Scienture.
- Scienture grew revenue faster in its latest fiscal year (+215.87% vs 0.00%).
About Scienture
SCNX stock →Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
About Silo Pharma
SILO stock →Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
SCNX vs SILO FAQ
Which is bigger, Scienture or Silo Pharma?
Scienture (SCNX) is larger, with a market capitalization of $4.07M compared with $3.69M for Silo Pharma (SILO).
Are Scienture and Silo Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.